Riskpilot← Back to searchSign inGet full accessUmeå Läkarkonsult AB
ABActiveOrg 5591389043Jämtebölevägen 9Hospital activities · NACE 8610Est. 20171 employees
Revenue 2025
SEK 299K
-22% vs 2024
EBITDA margin
75.0%
-27% vs 2024
Equity ratio
68.2%
Financial strength
Net profit 2025
SEK 178K
-27% vs 2024
| Revenue | SEK 299K | -22% |
| EBITDA | SEK 224K | -27% |
| Net profit | SEK 178K | -27% |
| Total assets | SEK 431K | -14% |
| Equity | SEK 294K | -9% |
| Employees | 1 | — |
Legal name
Umeå Läkarkonsult AB
Org number
5591389043
Legal form
Aktiebolag
NACE code
8610 · Hospital activities
Founded
12 december 2017
Share capital
SEK 50 000
Employees
1 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Bolaget ska bedriva medicinsk konsult- och utbildningsverksamhet inom hälso- och sjukvård, friskvård och rehabilitering. Föredrag och undervisning. Bemanningsverksamhet, handel med värdepapper samt idka därmed förenlig verksamhet.
Address
Jämtebölevägen 9
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 379 | 332 | 347 | 386 | 299 |
| Staff expenses | — | — | −11 | −10 | −10 |
| EBITDA | 313 | 253 | 229 | 308 | 224 |
| Depreciation & amort. | −0 | −0 | — | — | — |
| EBIT | 313 | 253 | 229 | 308 | 224 |
| Net financials | — | — | 0 | 0 | 0 |
| Profit before tax | 313 | 252 | 229 | 308 | 224 |
| Tax | −65 | −52 | −48 | −65 | −46 |
| Net profit | 248 | 200 | 181 | 243 | 178 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 484 | 468 | 414 | 503 | 431 |
| Equity | 316 | 266 | 261 | 324 | 294 |
| Long-term debt | 0 | 0 | — | — | — |
| Short-term debt | 167 | 201 | 153 | 179 | 137 |
| Total debt | 167 | 201 | 153 | 179 | 137 |
EBITDA margin
75.0%
This company
15.8%
Market median
+375% vs market
20212025
Equity ratio
68.2%
This company
38.2%
Market median
+79% vs market
20212025
Return on equity
60.5%
This company
18.4%
Market median
+229% vs market
20212025
Net profit margin
59.5%
This company
8.1%
Market median
+635% vs market
20212025
Asset turnover
0.69×
This company
1.12×
Market median
-38% vs market
20212025
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
No data on file.
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Board of Directors | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Umeå Läkarkonsult AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Ida Josefin Gideonsson | Board of Directors | 0 companies |
| I Pär S E Gideonsson | Deputy Board Member | 0 companies |